Scientists at the University of Illinois say a study of an enzyme that causes severe acute respiratory syndrome may lead to new drugs.
"By unlocking the three-dimensional structure of this enzyme -- known as papain-like-protease -- we now have a molecular road map to design new drugs that could potentially treat SARS-infected patients, or perhaps patients suffering from other SARS-related illnesses such as the common cold, bronchitis or pneumonia," said Andrew Mesecar, Illinois associate professor of pharmaceutical biotechnology.
"We are attempting to use the same approach that has been accomplished in designing effective drugs against HIV protease, which has led to the development of new drugs to fight the AIDS virus," he added.
SARS was first reported in Asia in early 2003 and then spread to more than 29 countries in North and South America, Europe and Asia before it was contained.
According to the World Health Organization, 8,098 people worldwide were diagnosed with SARS during the 2003 outbreak; 774 died. There were 29 cases reported in the United States, with no fatalities.
The research appeared in the March 27 issue of the Proceedings of the National Academy of Sciences.
Copyright 2006 by United Press International
Related stories:
All Sweeteners May Not Be the Same When Managing Type 2 Diabetes and Complications
(PhysOrg.com) -- Recent research by Kalidas Shetty of the University of Massachusetts Amherst and Lena Galvez Ranilla of the University of San Paolo, Brazil, shows that when it comes to managing Type 2 diabetes, all sweeteners may not be the same. Some sweeteners, including date sugar and less refined, dark brown sugars, showed potential for managing Type 2 diabetes and related complications − information that could help Type 2 diabetics make better dietary choices.
Researchers build new model of bio-exploration
Two land-grant universities have developed a new approach to global bio-exploration, one that returns most of the fruits of discovery to the countries that provide the raw materials on which the research depends.
Body's anti-HIV drug explained
Humans have a built-in weapon against HIV, but until recently no one knew how to unlock its potential.
Genome sequences of 2 malaria parasites defined
Professor Alan Cowman, Professor Brendan Crabb, Dr Paul Gilson and Dr Toby Sargeant are WEHI members of international research teams that have made significant discoveries about two deadly malaria parasites,
Plasmodium knowlesi and
Plasmodium vivax.
Protection for stressed-out bacteria identified
An international team of researchers is a step closer to understanding the spread of deadly diseases such as listeriosis, after observing for the first time how bacteria respond to stress.
Food for thought -- regulating energy supply to the brain during fasting
If the current financial climate has taught us anything, it's that a system where over-borrowing goes unchecked eventually ends in disaster. It turns out this rule applies as much to our bodies as it does to economics. Instead of cash, our body deals in energy borrowed from muscle and given to the brain.
Groundbreaking discovery may lead to stronger antibiotics
The last decade has seen a dramatic decline in the effectiveness of antibiotics, resulting in a mounting public health crisis across the world. A new breakthrough by University of Virginia researchers provides physicians and patients a potential new approach toward the creation of less resistant and more effective antibiotics.
Natural Viagra? 'Horny goat weed' shows promise in lab studies
Move over, Viagra! Researchers in Italy report that an ancient Chinese herbal remedy known as "horny goat weed" shows potential in lab studies as source for new future drugs to treat erectile dysfunction (ED). The study, which provides scientific evidence supporting the herb's well-known use as a natural aphrodisiac, is scheduled for the October 24 issue of ACS'
Journal of Natural Products.